LifeTech Scientific

LifeTech Scientific EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of LifeTech Scientific (1302.HK) as of Oct 3, 2026 is 214.96 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 199.05 M CNY — a change of 8.00% (higher).

EBITDA

214.96 MCNY

YoY

8.00%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of LifeTech Scientific is 2026 214.96 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of LifeTech Scientific was 2025 199.05 M CNY. It decreases by 8.00% higher compared to the previous year.

The LifeTech Scientific EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
191.08 M CNY
Jan 1, 2019
225.86 M CNY
Jan 1, 2020
314.03 M CNY
Jan 1, 2021
391.06 M CNY
Jan 1, 2022
449.90 M CNY
Jan 1, 2023
396.36 M CNY
Jan 1, 2024
199.05 M CNY
Jan 1, 2025
214.96 M CNY
The LifeTech Scientific EBITDA history
YEAREBITDAYoY
214.96 MCNY+8.00%
199.05 MCNY-49.78%
396.36 MCNY-11.90%
449.90 MCNY+15.05%
391.06 MCNY+24.53%
314.03 MCNY+39.04%
225.86 MCNY+18.21%
191.08 MCNY-14.58%
223.68 MCNY+74.91%
127.88 MCNY+16.34%
109.92 MCNY+89.72%
57.94 MCNY—
Access this data via the Eulerpool API

LifeTech Scientific Stock analysis

What does LifeTech Scientific do? LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LifeTech Scientific stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of LifeTech Scientific is 214.96 M CNY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of LifeTech Scientific changed from 199.05 M CNY to 214.96 M CNY, representing a 8.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) LifeTech Scientific since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s LifeTech Scientific historically and in real time.

Access this data via the Eulerpool API

Income Statement — LifeTech Scientific

All Key Metrics — LifeTech Scientific